Satellite symposium1 Sponsored by Novonordisk | Thursday 16 October 17:30~18:00 | Place: Room 2 Chair: Sei Hyun Baik |
Hyuk Sang Kwon The Catholic University of Korea, Korea |
SS1 The new solution to T2DM: human GLP-1 analogue, liraglutide |
Satellite symposium2 Sponsored by Lilly | Thursday 16 October 17:30~18:00 | Place: Room 3 Chair: Jae Myung Yu |
Jae Hyuk Lee Myongji Hospital, Korea |
SS2 The role of pre-mixed insulin for patients with T2DM comparing with basal insulin treatment |
Breakfast symposium 1 Sponsored by Daewoong | Friday 17 October 07:00~08:00 | Place: Grand Ballroom, MVL Hotel Chair: Yong Seong Kim |
Woo Je Lee University of Ulsan, Korea |
BS1 Importance of awareness about hypoglycemia risk and prevention of cardio vascular complications in T2DM |
Breakfast symposium 2 Sponsored by Takeda | Friday 17 October 07:00~08:00 | Place: Grand Ballroom, MVL Hotel Chair: Kyung Soo Ko |
Eun Jung Rhee Sungkyunkwan University, Korea |
BS2 Efficacy and durability: it's time to think of 10-year plan for our patients |
Breakfast symposium 3 Sponsored by Boehringer Ingelheim | Saturday 18 October 07:30~08:30 | Place: Grand Ballroom, MVL Hotel Chair: Han Kyung Ah |
Eun Seok Kang Yonsei University, Korea |
BS3 DPP4 inhibitor, Linagliptin, to simplify treatment for a broad range of T2DM patients (2014 ADA highlight) |
Breakfast symposium 4 Sponsored by Handok | Saturday 18 October 07:30~08:30 | Place: Grand Ballroom, MVL Hotel Chair: Kang Seo Park |
Eun Gyoung Hong Hallym University, Korea |
BS4 Metabolic karma - the essential solution in T2DM |
Luncheon symposium 1 Sponsored by MSD | Friday 17 October 11:50~13:00 | Place: Room 2 Chair: Yong Ki Kim |
Cheol-Young Park Sungkyunkwan University, Korea |
LS1 Comprehensive approach for diabetic dyslipidemia management |
Luncheon symposium 2 Sponsored by Astrazeneca | Friday 17 October 11:50~13:00 | Place: Room 3 Chair: Seok Won Park |
Young Min Cho Seoul National University, Korea |
LS2 "Update on emerging novel agents for the treatment of type 2 diabetes: focus on dapagliflozin |
Luncheon symposium 3 Sponsored by Sanofi Aventis | Friday 17 October 11:50~13:00 | Place: Room 4 Chair: Hak Chul Jang |
Sung Hee Choi Seoul National University, Korea |
LS3 Management of hyperglycemia in patients with type 2 diabetes uncontrolled on a combination of sulfonylurea and metformin: results of MOHAS disease registry in Korea |
Luncheon symposium 4 Sponsored by Otsuka | Friday 17 October 11:50~13:00 | Place: Room 5 Chair: Cheol Soo Choi |
Kyoung Im Cho Kosin University, Korea |
LS4 Benefit of carotid ultrasonography and antiplatelet therapy for diabetic patients |
Luncheon symposium 5 Sponsored by Novartis | Saturday 18 October 12:10~13:30 | Place: Room 2 Chair: Sung-Soo Koong |
Kyung Mook Choi Korea University, Korea |
LS5 Destination diabetes: exploring the pathways and junctions of the T2DM |
Luncheon symposium 6 Sponsored by JW Pharmaceutical | Saturday 18 October 12:10~13:30 | Place: Room 3 Chair: Kyung Ho Lim |
Koutaro Yokote Chiba University, Japan |
LS6 Lipid management in diabetes: potential role of pitavastatin in Asian patients |
Luncheon symposium 7 Sponsored by Pfizer | Saturday 18 October 12:10~13:30 | Place: Room 4 Chair: Kyu Jeung Ahn |
In-Kyung Jeong Kyung-Hee University, Korea |
LS7 Novel approach of dyslipidemia management in T2DM based on updated guideline & clinical trial |